These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 20962509

  • 21. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [Abstract] [Full Text] [Related]

  • 22. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
    Horm Res; 1997 Jul; 47(1):17-22. PubMed ID: 9010713
    [Abstract] [Full Text] [Related]

  • 23. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.
    Jääskeläinen J, Voutilainen R.
    Pediatr Res; 1997 Jan; 41(1):30-3. PubMed ID: 8979286
    [Abstract] [Full Text] [Related]

  • 24. Congenital adrenal hyperplasia: lessons from a multinational study.
    Frisch H, Waldhauser F, Lebl J, Solyom J, Hargitai G, Kovacs J, Pribilincova Z, Krzisnik C, Battelino T, MEWPE-CAH Study Group.
    Horm Res; 2002 Jan; 57 Suppl 2():95-101. PubMed ID: 12065936
    [Abstract] [Full Text] [Related]

  • 25. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
    J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
    [Abstract] [Full Text] [Related]

  • 26. Long-term Growth in Congenital Adrenal Hyperplasia.
    Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
    Indian J Pediatr; 2019 Feb; 86(2):154-158. PubMed ID: 30097840
    [Abstract] [Full Text] [Related]

  • 27. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
    Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
    Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
    [Abstract] [Full Text] [Related]

  • 28. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
    Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
    [Abstract] [Full Text] [Related]

  • 29. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
    Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
    J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
    [Abstract] [Full Text] [Related]

  • 30. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Körner A, Kiess W, Kratzsch J, Dörr HG.
    Acta Paediatr; 2009 May 01; 98(5):885-91. PubMed ID: 19236311
    [Abstract] [Full Text] [Related]

  • 31. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D.
    J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598
    [Abstract] [Full Text] [Related]

  • 32. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
    Stikkelbroeck NM, Van't Hof-Grootenboer BA, Hermus AR, Otten BJ, Van't Hof MA.
    J Clin Endocrinol Metab; 2003 Aug 01; 88(8):3525-30. PubMed ID: 12915631
    [Abstract] [Full Text] [Related]

  • 33. Hypertension in children with congenital adrenal hyperplasia.
    Maccabee-Ryaboy N, Thomas W, Kyllo J, Lteif A, Petryk A, Gonzalez-Bolanos MT, Hindmarsh PC, Sarafoglou K.
    Clin Endocrinol (Oxf); 2016 Oct 01; 85(4):528-34. PubMed ID: 27105393
    [Abstract] [Full Text] [Related]

  • 34. Final height of patients with classical congenital adrenal hyperplasia.
    Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
    Turk J Pediatr; 2009 Oct 01; 51(6):539-44. PubMed ID: 20196386
    [Abstract] [Full Text] [Related]

  • 35. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood.
    Yu AC, Grant DB.
    Acta Paediatr; 1995 Aug 01; 84(8):899-903. PubMed ID: 7488814
    [Abstract] [Full Text] [Related]

  • 36. [Growth and adult height in patients with congenital adrenal hyperplasia].
    Kolousková S, Zemková D, Snajderová M, Lebl J.
    Cas Lek Cesk; 1995 Nov 01; 134(21):689-91. PubMed ID: 8556761
    [Abstract] [Full Text] [Related]

  • 37. Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.
    Bonfig W, Roehl FW, Riedl S, Dörr HG, Bettendorf M, Brämswig J, Schönau E, Riepe F, Hauffa B, Holl RW, Mohnike K, AQUAPE CAH Study Group.
    Am J Hypertens; 2016 Feb 01; 29(2):266-72. PubMed ID: 26071487
    [Abstract] [Full Text] [Related]

  • 38. Growth and Metabolic Syndrome (MetS) criteria in young children with classic Congenital Adrenal Hyperplasia (CAH) treated with corticosteroids (CS).
    Abdel Meguid SE, Soliman AT, De Sanctis V, Abougabal AMS, Ramadan MAEF, Hassan M, Hamed N, Ahmed S.
    Acta Biomed; 2022 Oct 26; 93(5):e2022304. PubMed ID: 36300207
    [Abstract] [Full Text] [Related]

  • 39. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
    Hauffa BP, Winter A, Stolecke H.
    Klin Padiatr; 1997 Oct 26; 209(2):71-7. PubMed ID: 9113619
    [Abstract] [Full Text] [Related]

  • 40. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
    Rasat R, Espiner EA, Abbott GD.
    N Z Med J; 1995 Aug 11; 108(1005):311-4. PubMed ID: 7644165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.